MRC-Q
Live / Allowed — Published for opposition (as of 08 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79432338
- Mark type
- Stylized text
- Filed
- 17 Jul 2025
- Published for opposition
- 08 Sept 2026
- Attorney of record
- Corey K. Cho
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceutical agents for the treatment of mitochondrial diseases, ophthalmic diseases, neurodegenerative diseases, cardiovascular diseases, ischemic injuries, muscle wasting diseases, metabolic disorders, cancer, age-related conditions, In Vitro Fertilization, and ex vivo use in cell culture and cell processing, namely, cell expansion, improvement of cell quality and function, and improvement of viability of cells; biopharmaceutical agents for cosmetic and health supplement use; pharmaceutical preparations for the treatment of mitochondrial diseases, ophthalmic diseases, neurodegenerative diseases, cardiovascular diseases, ischemic injuries, muscle wasting diseases, metabolic disorders, cancer, age-related conditions, In Vitro Fertilization, and ex vivo use in cell culture and cell processing, namely, cell expansion, improvement of cell quality and function, and improvement of viability of cells; pharmaceutical preparations for cosmetic and health supplement use
Owner
- LUCA Science Inc., JP
- LUCA Science Inc., JP
Prosecution history
- 08 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Sept 2026 — PUBLISHED FOR OPPOSITION
- 02 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 26 Feb 2026 — REFUSAL PROCESSED BY IB
- 06 Feb 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 06 Feb 2026 — REFUSAL PROCESSED BY MPU
- 11 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 10 Dec 2025 — NON-FINAL ACTION WRITTEN
- 04 Dec 2025 — ASSIGNED TO EXAMINER
- 14 Sept 2025 — APPLICATION FILING RECEIPT MAILED